Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Veracyte Inc (NQ: VCYT ) 29.77 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Sep 5, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Veracyte Inc < Previous 1 2 3 4 5 6 Next > Veracyte Announces Third Quarter 2021 Financial Results November 09, 2021 From Veracyte, Inc. Via Business Wire Veracyte Announces Immunoscore Colon Cancer Test Included in ESMO Clinical Practice Guidelines Adapted for Pan-Asia November 05, 2021 From Veracyte, Inc. Via Business Wire New Publication Reinforces Clinical Utility of Afirma Genomic Sequencing Classifier in Thyroid Cancer Diagnosis November 03, 2021 From Veracyte, Inc. Via Business Wire Veracyte Announces New Data To Be Presented at SITC 2021 Will Highlight Company’s Immuno-Oncology Capabilities November 02, 2021 From Veracyte, Inc. Via Business Wire New Data Demonstrate Clinical Utility of Veracyte’s Decipher Prostate Genomic Classifier in Tailoring Treatment for Prostate Cancer Patients Experiencing Progression After Surgery October 26, 2021 From Veracyte, Inc. Via Business Wire Data Presented at ASTRO 2021 Validate Prognostic Value of Decipher Prostate Genomic Test in Newly Diagnosed, Clinically High-Risk Prostate Cancer October 25, 2021 From Veracyte, Inc. Via Business Wire New Data to be Presented at ASTRO 2021 Further Validate Clinical Utility of Veracyte’s Decipher Prostate Genomic Classifier October 14, 2021 From Veracyte, Inc. Via Business Wire New Publication Demonstrates Ability of Veracyte’s Decipher Bladder Test to Identify Tumors Most Likely to Respond to Chemotherapy October 13, 2021 From Veracyte, Inc. Via Business Wire Veracyte to Release Third Quarter 2021 Financial Results on November 9, 2021 October 12, 2021 From Veracyte, Inc. Via Business Wire New Clinical Utility Data Confirm Veracyte’s Envisia Genomic Classifier Increases Accuracy and Confidence in IPF Diagnosis October 11, 2021 From Veracyte, Inc. Via Business Wire Veracyte Announces New Expanded Data at CHEST Underscoring Percepta Nasal Swab Test’s Ability to Improve Early Lung Cancer Assessment October 11, 2021 From Veracyte, Inc. Via Business Wire New Data to be Presented at CHEST 2021 Showcase Clinical Performance of Veracyte’s Genomic Diagnostic Tests in Lung Cancer and Interstitial Lung Disease October 06, 2021 From Veracyte, Inc. Via Business Wire Veracyte Announces that New NCCN Guidelines Uniquely Recommend Use of Decipher Prostate Genomic Test Score to Guide Specific Treatment for Men Following Radical Prostatectomy September 14, 2021 From Veracyte, Inc. Via Business Wire Veracyte Further Strengthens Medical Team with Appointment of Joshua Klopper, M.D., as Medical Director of Endocrinology September 01, 2021 From Veracyte, Inc. Via Business Wire Veracyte to Participate in Morgan Stanley 19th Annual Global Healthcare Conference August 31, 2021 From Veracyte, Inc. Via Business Wire Veracyte Named a San Francisco Bay Area “Top Workplace” for Eighth Consecutive Year August 23, 2021 From Veracyte, Inc. Via Business Wire Veracyte Completes Acquisition of HalioDx August 03, 2021 From Veracyte Via Business Wire Veracyte Announces Second Quarter 2021 Financial Results July 29, 2021 From Veracyte, Inc. Via Business Wire New Study Suggests Decipher Prostate Biopsy Test May Help Guide Use of Active Surveillance in Prostate Cancer July 27, 2021 From Veracyte, Inc. Via Business Wire Veracyte Appoints Rebecca Chambers as Executive Vice President and Chief Financial Officer, Further Positioning Company for Global Growth July 12, 2021 From Veracyte, Inc. Via Business Wire Veracyte to Release Second Quarter 2021 Financial Results on July 29, 2021 July 08, 2021 From Veracyte, Inc. Via Business Wire Veracyte Announces Key Appointments to Executive Leadership Team, Supporting Global Expansion July 08, 2021 From Veracyte, Inc. Via Business Wire Veracyte Announces Two Pre-Eminent Physician Appointments, Further Strengthening Medical Team July 01, 2021 From Veracyte, Inc. Via Business Wire New Data Published in JAMA Oncology Demonstrate Prognostic Utility of Veracyte’s Decipher Prostate Genomic Classifier in Locally Advanced Prostate Cancer June 14, 2021 From Veracyte, Inc. Via Business Wire Veracyte Receives Final Medicare Coverage Policies for Decipher Bladder June 04, 2021 From Veracyte, Inc. Via Business Wire CORRECTING and REPLACING Veracyte to Present at Upcoming Investor Conferences June 02, 2021 From Veracyte, Inc. Via Business Wire Veracyte to Present at Upcoming Investor Conferences June 02, 2021 From Veracyte, Inc. Via Business Wire Veracyte to Acquire HalioDx, Positioning for Global Cancer Diagnostics Growth June 01, 2021 From Veracyte, Inc. Via Business Wire Veracyte to Present at Upcoming Investor Conferences May 26, 2021 From Veracyte Via Business Wire Veracyte Announces New Data Demonstrating Afirma Xpression Atlas Identifies Clinically Relevant Gene Fusions in Thyroid Cancer FNA Samples May 26, 2021 From Veracyte, Inc. Via Business Wire < Previous 1 2 3 4 5 6 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.